Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James E Melnyk

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of the American Chemical Society|August 4, 2012
The innate immune protein Nod2 binds directly to MDP, a bacterial cell wall fragmentCatherine Leimkuhler Grimes, Lushanti De Zoysa Ariyananda, James E Melnyk, et al.
Journal of the American Chemical Society|June 3, 2015
Peptidoglycan Modifications Tune the Stability and Function of the Innate Immune Receptor Nod2James E Melnyk, Vishnu Mohanan, Amy K Schaefer, et al.
Bioorganic & Medicinal Chemistry|October 17, 2020
The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cellsJames E Melnyk, Veronica Steri, Hao G Nguyen, et al.
ACS Chemical Biology|July 15, 2017
Membrane Association Dictates Ligand Specificity for the Innate Immune Receptor NOD2Amy K Schaefer, James E Melnyk, Michael M Baksh, et al.
Oncogene|January 28, 2022
Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCβ1James E Melnyk, Veronica Steri, Hao G Nguyen, et al.
Biochemistry|August 10, 2017
Crohn's Disease Variants of Nod2 Are Stabilized by the Critical Contact Region of Hsp70Amy K Schaefer, Hannah C Wastyk, Vishnu Mohanan, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variantAnn-Kathrin Reuschl, Lucy G Thorne, Lorena Zuliani-Alvarez, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Genome-wide CRISPR screens identify PTGES3 as a novel AR modulatorHaolong Li, James E Melnyk, Becky Xu Hua Fu, et al.
Nature Genetics|November 5, 2025
Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancerHaolong Li, James E Melnyk, Becky Xu Hua Fu, et al.
Nature Communications|September 27, 2023
Proteomic and genetic analyses of influenza A viruses identify pan-viral host targetsKelsey M Haas, Michael J McGregor, Mehdi Bouhaddou, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of the American Chemical Society|August 4, 2012
The innate immune protein Nod2 binds directly to MDP, a bacterial cell wall fragmentCatherine Leimkuhler Grimes, Lushanti De Zoysa Ariyananda, James E Melnyk, et al.
Journal of the American Chemical Society|June 3, 2015
Peptidoglycan Modifications Tune the Stability and Function of the Innate Immune Receptor Nod2James E Melnyk, Vishnu Mohanan, Amy K Schaefer, et al.
Bioorganic & Medicinal Chemistry|October 17, 2020
The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cellsJames E Melnyk, Veronica Steri, Hao G Nguyen, et al.
ACS Chemical Biology|July 15, 2017
Membrane Association Dictates Ligand Specificity for the Innate Immune Receptor NOD2Amy K Schaefer, James E Melnyk, Michael M Baksh, et al.
Oncogene|January 28, 2022
Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCβ1James E Melnyk, Veronica Steri, Hao G Nguyen, et al.
Biochemistry|August 10, 2017
Crohn's Disease Variants of Nod2 Are Stabilized by the Critical Contact Region of Hsp70Amy K Schaefer, Hannah C Wastyk, Vishnu Mohanan, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variantAnn-Kathrin Reuschl, Lucy G Thorne, Lorena Zuliani-Alvarez, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Genome-wide CRISPR screens identify PTGES3 as a novel AR modulatorHaolong Li, James E Melnyk, Becky Xu Hua Fu, et al.
Nature Genetics|November 5, 2025
Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancerHaolong Li, James E Melnyk, Becky Xu Hua Fu, et al.
Nature Communications|September 27, 2023
Proteomic and genetic analyses of influenza A viruses identify pan-viral host targetsKelsey M Haas, Michael J McGregor, Mehdi Bouhaddou, et al.
Pageof 2